Marker Therapeutics Inc (FRA:GX1)
€ 1.1 +0.010 (+0.92%) Market Cap: 19.60 Mil Enterprise Value: 9.88 Mil PE Ratio: 0 PB Ratio: 1.88 GF Score: 32/100